Resumen
Objetivo: Analizar las tendencias actuales en el uso de la anticoncepción reversible de acción prolongada (LARC) por mujeres en edad reproductiva, destacando beneficios, desafíos y factores que influyen en la adherencia. Métodos: Este estudio se realizó mediante una revisión integradora de la literatura en la base de datos PubMed, utilizando los descriptores “Anticonceptivos Reversibles de Acción Prolongada”, “Anticoncepción” y “Dispositivo Intrauterino”, combinados con el operador booleano AND. Se seleccionaron artículos publicados en los últimos seis años, en inglés o portugués, con acceso libre, excluyendo revisiones y artículos sin traducción disponible. Se incluyeron 22 artículos para su análisis. Resultados: Los LARC destacan por su alta efectividad, practicidad y fomento de la autonomía femenina, siendo especialmente útiles en adolescentes, mujeres en el posparto y aquellas con comorbilidades. No obstante, persisten desafíos como la falta de políticas públicas para la formación de profesionales y la difusión de información basada en evidencia científica. Los informes educativos refuerzan su uso, pero los temores infundados generan resistencia. Consideraciones finales: Los LARC ofrecen anticoncepción eficaz y sostenible, promoviendo la autonomía femenina. Ampliar su acceso depende de iniciativas que combatan la desinformación y fomenten la formación profesional, además de proporcionar información accesible para las mujeres.
Referencias
ALI M, et al. Expanding choice and access in contraception: an assessment of intrauterine contraception policies in low and middle-income countries. BMC Public Health, 2019; 19(1): 1707.
ANANT M, et al. Are myths surrounding long-acting reversible contraception the reason for a huge unmet need for spacing pregnancies? Journal of Family Medicine and Primary Care, 2021; 10(12): 4431-4437.
BOROVAC-PINHEIRO A, et al. Empowering Adolescent Mothers in the Choice of Contraceptive Methods at the Postpartum Period: Avoiding a Subsequent Pregnancy. Revista Brasileira de Ginecologia e Obstetrícia, 2019; 41(10): 607-612.
CHOO B, et al. Trends in different contraception methods among women attending the Melbourne Sexual Health Centre from 2011 to 2020. Public Health, 2024; 233: 130-136.
DARNEY B, et al. US "Safety Net" Clinics Provide Access to Effective Contraception for Adolescents and Young Women, 2017-2019. American Journal of Public Health, 2022; 112: S555-S562.
FERRO B, et al. Contracepção Reversível de Longa Duração na Adolescência: A Realidade de um Hospital Pediátrico Terciário em Portugal. Acta Médica Portuguesa, 2023; 36(6): 394-400.
GEMZELL-DANIELSSON K, et al. More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years. BMJ Sexual & Reproductive Health, 2021; 47(3): 228-230.
HOGMARK S, et al. Placement of an intrauterine device within 48 hours after early medical abortion-a randomized controlled trial. American Journal of Obstetrics & Gynecology, 2023; 228(1): 53.e1-53.e9.
JIN F, et al. Factors that influence the choice of long-acting reversible contraceptive use among adolescents post-abortion in Chongqing, China: a cross-sectional study. Journal of Obstetrics and Gynecology, 2024; 44(1): 2316625.
JUDGE-GOLDEN C, et al. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System. Journal of Womens Health (Larchmont), 2020; 29(12): 1586-1595.
LOTRIDGE J, et al. Long-acting reversible contraceptive use, active component service women, U.S. Armed Forces, 2016-2020. Medical Surveillance Monthly Report, 2021; 28(7): 2-10.
MAZZA D, et al. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial. American Journal of Obstetrics & Gynecology, 2020; 222(4S): S921.e1-S921.e13.
MELAMED M, et al. Contraceptive Preference, Continuation Rates, and Unintended Pregnancies in Patients with Comorbidities: A Prospective Cohort Study. Journal of Womens Health (Larchmont), 2021; 30(10): 1469-1475.
MUKAMUYANGO J, et al. Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy. American Journal of Obstetrics & Gynecology, 2020; 222(4S): S919.e1-S919.e12.
PAUL R, et al. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. American Journal of Obstetrics & Gynecology, 2020; 222(4): S884.e1–S884.e9.
REY C, et al. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont. Contraception, 2020; 101(5): 333-337.
RODRIGUEZ M, et al. Medicaid Policy Change and Immediate Postpartum Long-Acting Reversible Contraception. JAMA Health Forum, 2024; 5(6): e241359.
ROLAND N, et al. Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study. International Journal of Gynaecology and Obstetrics, 2023; 160(2): 594-603.
SATHITLOETSAKUM S, et al. The prevalence of contraceptive use among postpartum women and its associated factors during the early phase of COVID-19 outbreak: a time series study. Reproductive Health, 2024; 21(1): 80.
UJAH OI, KIRBY RS. Long-Acting Reversible Contraceptive Use by Rural-Urban Residence among Women in Nigeria, 2016-2018. International Journal of Environmental Research and Public Health, 2022; 19(20): 13027.
VAYNGORTIN T, et al. Adolescents' Acceptance of Long-Acting Reversible Contraception After an Educational Intervention in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 2020; 21(3): 640-646.
YI K, et al. Perceptions and Knowledge of Women Regarding Contraception and Current Trends in Contraceptive Use in Korea. Yonsei Medical Journal, 2022; 63(11): 999-1006.
